Home » PHARMAXIS OBTAINS LICENSE TO MANUFACTURE INHALATION POWDERS FOR HUMAN USE
PHARMAXIS OBTAINS LICENSE TO MANUFACTURE INHALATION POWDERS FOR HUMAN USE
Friday morning, Pharmaxis Ltd., a specialist pharmaceutical company, revealed that it obtained a Good Manufacturing Practices License from the Therapeutic Goods Administration or TGA to manufacture inhalation powders for human use that excludes microbiological testing.
Trading
Markets
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May